<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.investing.com/news/stock-market-news/novartis-nears-deal-to-buy-us-biotech-firm-medicines-co-for-about-7-billion-wsj-2026774"/>
    <meta property="og:site_name" content="Investing.com"/>
    <meta property="article:published_time" content="2019-11-23T00:00:00+00:00"/>
    <meta property="og:title" content="Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ"/>
    <meta property="og:description" content="Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ"/>
  </head>
  <body>
    <article>
      <h1>Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ</h1>
      <address><time datetime="2019-11-23T00:00:00+00:00">23 Nov 2019</time> by <a rel="author">Reuters</a></address>
      <p>(Reuters) - Swiss drugmaker Novartis AG (S:<a href="https://www.investing.com/equities/novartis">NOVN</a>) is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co (O:<a href="https://www.investing.com/equities/the-medicines-com">MDCO</a>) for about $7 billion, the Wall Street Journal reported on Saturday.</p>
      <p>The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the matter.</p>
      <p>Neither Novartis nor The Medicines Co were immediately available for comment on Saturday.</p>
    </article>
  </body>
</html>